We are live on ! Find out more
EAM

EULAV Asset Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 23.04%
This Fund
S&P 500
This Quarter Est. Return
+7.7%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$2.67B
AUM Growth
+$240M
Cap. Flow
+$105M
Cap. Flow %
3.94%
Top 10 Hldgs %
17.98%
Holding
319
New
17
Increased
107
Reduced
57
Closed
13

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$15M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$9.58M
3
ACN icon
Accenture
ACN
+$7.15M
4
AVGO icon
Broadcom
AVGO
+$6.73M
5
ADP icon
Automatic Data Processing
ADP
+$6.53M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$23M
2
ULTI
Ultimate Software Group Inc
ULTI
+$19.1M
3
MDSO
Medidata Solutions, Inc.
MDSO
+$7.95M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$5.33M
5
BDX icon
Becton Dickinson
BDX
+$3.8M

Sector Composition

Rank Sector Weight
1 Technology 25.98%
2 Healthcare 19.42%
3 Industrials 19.08%
4 Consumer Discretionary 11.89%
5 Financials 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACGL icon
51
Arch Capital
ACGL
$34.5B
$17.9M 0.67%
481,700
+19,100
+4% +$651K
POOL icon
52
Pool Corp
POOL
$6.95B
$17.6M 0.66%
92,300
+3,300
+4% +$596K
BMRN icon
53
BioMarin Pharmaceuticals
BMRN
$11.7B
$17.6M 0.66%
205,000
+112,000
+120% +$9.58M
CDNS icon
54
Cadence Design Systems
CDNS
$91.7B
$15.9M 0.6%
224,400
+55,700
+33% +$3.72M
NOC icon
55
Northrop Grumman
NOC
$76B
$15.8M 0.59%
48,900
– –
ICPT
56
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$15.7M 0.59%
197,000
+17,000
+9% +$1.52M
DXCM icon
57
DexCom
DXCM
$28.8B
$15.6M 0.58%
416,000
+152,000
+58% +$4.78M
FANG icon
58
Diamondback Energy
FANG
$56.2B
$15.6M 0.58%
143,000
+38,000
+36% +$3.97M
WEX icon
59
WEX
WEX
$6.35B
$15.5M 0.58%
74,400
-13,900
-16% -$2.8M
IEX icon
60
IDEX
IEX
$17.3B
$14.4M 0.54%
83,750
– –
INTU icon
61
Intuit
INTU
$86.3B
$13.9M 0.52%
53,200
+6,000
+13% +$1.52M
AVGO icon
62
Broadcom
AVGO
$1.85T
$13.6M 0.51%
471,000
+231,000
+96% +$6.73M
JKHY icon
63
Jack Henry & Associates
JKHY
$11B
$13.4M 0.5%
100,400
– –
TYL icon
64
Tyler Technologies
TYL
$13.3B
$13.3M 0.5%
61,600
– –
VRTX icon
65
Vertex Pharmaceuticals
VRTX
$122B
$13.2M 0.5%
72,000
– –
RLI icon
66
RLI Corp
RLI
$5.62B
$13M 0.49%
303,400
– –
NVDA icon
67
NVIDIA
NVDA
$4.72T
$13M 0.49%
3,160,000
+80,000
+3% +$332K
IT icon
68
Gartner
IT
$10.2B
$12.8M 0.48%
79,600
+5,800
+8% +$907K
AFG icon
69
American Financial Group
AFG
$11.8B
$12.7M 0.48%
123,800
+27,400
+28% +$2.76M
INFO
70
DELISTED
IHS Markit Ltd. Common Shares
INFO
$12.7M 0.48%
199,054
– –
SBAC icon
71
SBA Communications
SBAC
$19.3B
$12.4M 0.47%
55,200
-300
-0.5% -$63.3K
STZ icon
72
Constellation Brands
STZ
$22.3B
$12.2M 0.46%
62,000
-3,000
-5% -$586K
CSL icon
73
Carlisle Companies
CSL
$15B
$12.2M 0.46%
86,800
+4,300
+5% +$578K
DPZ icon
74
Domino's
DPZ
$11.7B
$12.1M 0.45%
43,500
– –
MTN icon
75
Vail Resorts
MTN
$5.45B
$11.8M 0.44%
53,000
-2,000
-4% -$444K
1 2
3
4 5

Similar funds

LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return

EULAV Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, EULAV Asset Management held 319 positions worth $2.67B, up 9.9% from $2.43B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

EULAV Asset Management deployed $105M of net new capital in Q2 2019, opening 17 new positions and adding to 107 existing holdings. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 110,000 shares worth $4.82M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $5.33M trimmed.

  • EULAV Asset Management's largest Q2 2019 buy was Biohaven Pharmaceutical Holding Company Ltd.: 110,000 shares worth $4.82M.
  • EULAV Asset Management added most to Union Pacific in Q2 2019, an estimated $15M increase.
  • EULAV Asset Management's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $5.33M.
  • EULAV Asset Management fully exited Celgene Corp in Q2 2019, selling an estimated $23M.
  • EULAV Asset Management's ten largest holdings make up 18% of its $2.67B portfolio in Q2 2019.
  • EULAV Asset Management opened 17 new positions and closed 13 in Q2 2019.
  • EULAV Asset Management's portfolio value rose 9.9% quarter-over-quarter to $2.67B.

Based on EULAV Asset Management's 13F filing for Q2 2019, filed 5 Aug 2019.